|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 592 articles |
 Page 1 of 8 
|
NZ RMI's 2008 election manifesto: focus on new drugs access ; R&D ince...
March 31, 2008
FDA launches safety review of Boeh Ing's Spiriva as pooled analysis sh...
March 31, 2008
EFPIA Japan reveals its position on eliminating the vaccine gap.
March 31, 2008
Kenya health sector reforms should see parallel importing of drugs and...
March 31, 2008
PharmAthene to buy Avecia business.
March 31, 2008
Potential of Russia's biotech sector.
March 31, 2008
Tongjitang buys Qinghai Pulante.
March 31, 2008
Isolagen sells Swiss facility for $6.4M.
March 31, 2008
Combination vaccines hold potential in the South African pediatric mar...
March 31, 2008
Market slowdown for dyslipidemia drugs.
March 31, 2008
Merck & Co's Gardasil gets priority US review.
March 31, 2008
CytRx responds to FDA's Ph IIb hold on ALS drug.
March 31, 2008
Pharming to resubmit Rhucin MAA.
March 31, 2008
EMEA restricts use of Millennium/J&J's Velcade.
March 31, 2008
CHMP recommends expanded label for Zevalin.
March 31, 2008
Abbott and Takeda agree deal to dissolve their US joint venture TAP.
March 31, 2008
Japan's No 1 generics group formed.
March 31, 2008
New heads for Novartis drug development as James Shannon departs.
March 31, 2008
TAP/Takeda appointments post-JV dissolution.
March 31, 2008
Steve Glass joins BioMarin as VP and general manager Europe.
March 31, 2008
Alain Beaudet named president of CIHR in Canada.
March 31, 2008
Stephamie Kelly named Actelion UK/Ireland brand manager.
March 31, 2008
Peter Edman becomes CSO at Biovitrum.
March 31, 2008
Geris buying of Indar shares "could be illegal," says Biotin.
March 31, 2008
pSivida amends Medidur deal with Alimera.
March 31, 2008
$5.8M Defense Dept contract for PharmAthene.
March 31, 2008
Pharming grants EIP rights to Rhucin in Turkey.
March 31, 2008
Celgene's amrubicin gets US OD designation.
March 31, 2008
Shire signs US co-promotion deal with TAP for Lialda.
March 31, 2008
Ferring to distribute and sell Millennium Biotech's Resurgex in Canada...
March 31, 2008
Daiichi Sankyo extends MorphoSys accord.
March 31, 2008
Sanofi-Aventis to help market Lilly's Cialis in USA.
March 31, 2008
EMEA warns of liver injury with Tysabri.
March 31, 2008
Big Pharma rushing to get foothold in emerging markets, despite challe...
March 31, 2008
Japan stock market week to March 24, 2008.
March 31, 2008
XTL Biopharma licenses preclinical antiviral program to Presidio for u...
March 31, 2008
Hollis-Eden's 4th-qtr net loss narrows to $5.2M on payments for Triole...
March 31, 2008
"Last chance" cancer drugs for UK patients.
March 31, 2008
Lilly settles Zyprexa Alaska case for $15M.
March 31, 2008
Biovail to pay $10M over SEC charges.
March 31, 2008
Cost-cutting by drugmakers in Germany.
March 31, 2008
China Biopharma to launch MNC's drugs.
March 31, 2008
UPDATE: US heparin deaths rise to 19, contaminant identified as dietar...
March 31, 2008
California drug RFID scheme faces delays.
March 31, 2008
58.5% of Actemra patients achieve ACR20.(Clinical report)
March 31, 2008
Levitra helps ED patients with high cholesterol.
March 31, 2008
Regeneron's Arcalyst available in USA.
March 31, 2008
Iomai's patch adjuvants flu vacc efficacy to 73%.
March 31, 2008
LB analysts: Shire is "heavily" over-valued.
March 31, 2008
AstraZeneca's Zactima "will earn 5% of NSCLC patients by 2016".
March 31, 2008
Project to study genetic basis of longevity in Parsi community.
March 31, 2008
Honeywell ups production of Aclar for pharma industry.
March 31, 2008
Corcept initiates fourth Ph II Corlux study.(Clinical report)
March 31, 2008
Medarex gets Centocor milestone.
March 31, 2008
US pharmaceutical R&D reached record level in 2007, $58.8B invested in...
March 31, 2008
E-mail drug alerts for US physicians launched.
March 31, 2008
40,000 HIV/AIDS patients in China receive ARVs, govt reports.
March 31, 2008
UK regulator orders infant cough remedy ban for under 2 yr olds.
March 31, 2008
Stock Commentary - Europe - week to March 24, 2008.
March 31, 2008
Stock Commentary - New York week to March 24, 2008.
March 31, 2008
US pres candidate's anti-pharma "jihad" would cost $40B in 10 years.
March 31, 2008
Saudi Arabia publishes biosimilars regulation.
March 31, 2008
BioAlliance gains three more EU Loramyc approvals.
March 31, 2008
Pieris raises 25M euros in financing round.
March 31, 2008
Akesis closes $2M placing.
March 31, 2008
Wyeth milestone for ArQule on AD drug.
March 31, 2008
UK drugmaker confidence crashes.
March 31, 2008
Belgium's drugmakers welcome 26 new drugs.
March 31, 2008
Delay to EU approval of GSK's Tyverb as EC considers liver enzyme elev...
March 31, 2008
Genzyme withdraws Evoltra label extension.
March 31, 2008
US MDs do not Rx to HLD guidelines.
March 31, 2008
CVS pays c$37M to settle US Rx case.
March 31, 2008
US drug price growth modest, says PhRMA.
March 31, 2008
Locaserin trial passes 1-year safety review.
March 31, 2008
Cardiome seeks partner to further vernakalant.(Clinical report)
March 31, 2008
|
1